Novo Nordisk's new weight loss pill, Wegovy, is off to a strong start in the U. S. Analysts say it was prescribed over 18, 000 times in its first full week. This is a big deal because it shows people are interested in a pill they can take instead of a shot. The race to make the best weight loss pil
CHO cells are like tiny factories. They make important medicines that help people fight diseases. But they are not very efficient. Scientists have been trying to make them better for years. They have tried many different methods. Some of these methods work well. But the results are not as good as ho
In a significant stride for medicine, a new drug combo is showing promise for people with a tough type of blood cancer. The combo, AB8939 plus venetoclax, is showing positive results in four patients who had run out of other options. These patients had a complex form of acute myeloid leukemia (AML),
A pharmaceutical company is making waves in the medical world. They are set to share big news about their latest treatments. On January 5, 2026, they will host a conference call. This call will update everyone on their progress and share results from a recent study. The company is known for its foc
The U. S. Food and Drug Administration (FDA) has given the green light to a new drug called Nereus, designed to tackle motion sickness. This approval is a big deal because it's the first new treatment for this condition in over 40 years. The drug, also known as tradipitant, works by blocking a speci
In a big move, Bluejay Capital Partners has teamed up with Quality Life Science Logistics & Transportation (QLS). This isn't just any old partnership. It's a recapitalization deal that's set to shake things up in the world of cold chain logistics. QLS, based in Coopersville, Michigan, is no small p
Scientists have found a clever new way to make special molecules called α-CF3 allylamines. These molecules are super important in making medicines, pesticides, and other useful materials. The problem was that making them wasn't easy or efficient. The new method uses a special kind of chemistry call
Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's exp
Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s
Scientists have found a clever way to make special molecules using light. They used a simple method that doesn't need metals or strong chemicals. Instead, they used a special compound called trifluoromethyl thianthrenium triflate, or TT-CF3+OTf-, which is easy to make and stable in air. This method
